Biomind Labs Inc Strategic Asset Allocation Index
Biomind Labs Inc strategic asset allocation index. Biomind Labs Inc (BMND) has a Strategic Asset Allocation Index of 4.6% as of March 2022. Strategic assets (PP&E of CA$77.46K plus long-term investments of CA$-) total CA$77.46K, measured against net assets of CA$1.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Biomind Labs Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Biomind Labs Inc (2021–2021)
Strategic asset allocation index of Biomind Labs Inc from 2021 to 2021. This chart shows how Biomind Labs Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of March 2022, the index stands at 4.6%, representing strategic assets of CA$77.46K against net assets of CA$1.70 Million CAD. Check Biomind Labs Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Biomind Labs Inc Strategic Asset Allocation Index by Year (2021–2021)
Biomind Labs Inc strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Biomind Labs Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BMND market cap.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 4.0% | CA$88.37K | CA$88.37K | CA$- | CA$2.19 Million | — |